Form 4 for IMNM Immunome Inc.
Accepted 2026-09-15 16:30:38 ET · period of report 2026-09-11 · accession 0001993684-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-15 16:30 | 2026-09-11 | IMNM | Higgins Jack | CSO | M - OptEx | $1.35 | +18.0K | 78.2K | +30% | +$24.3K |
| DT | 2026-09-15 16:30 | 2026-09-11 | IMNM | Higgins Jack | CSO | S - Sale+OE | $25.32 | -13.2K | 65.0K | -17% | -$334.2K |
| DT | 2026-09-15 16:30 | 2026-09-11 | IMNM | Higgins Jack | CSO | G - Gift | $0.00 | -8,800 | 56.2K | -14% | $0 |
| DT | 2026-09-15 16:30 | 2026-09-11 | IMNM | Higgins Jack | CSO | M - OptEx | $0.00 | +18.0K | 133.8K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | M | A | 18,000 | $1.35 | 78,250 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-11 | S | D | 13,200 | $25.32 | 65,050 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025. |
| 3 | Common | Common Stock | 2026-09-11 | G | D | 8,800 | $0.00 | 56,250 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2026-09-11 | M | A | 18,000 | $0.00 | 133,840 | D | $1.35 · — to 2032-06-23 | 18,000 Common Stock | (F3) 25% of the shares subject to the options vested on May 1, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options vests every month thereafter, subject to the Reporting Person's continuous service through each such vesting date. |